Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$706M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$439M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$413M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$431M |
| 2 |
Walt Disney
DIS
|
+$223M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$213M |
| 4 |
Halliburton
HAL
|
+$211M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.34% |
| 2 | Financials | 5.75% |
| 3 | Healthcare | 5.71% |
| 4 | Consumer Discretionary | 5.08% |
| 5 | Industrials | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
QVCGA
4676
CALL
DELISTED
QVC Group Inc Series A
QVCGA
| $271K | ﹤0.01% |
251
-15
| -6% | -$15.8K |
|
|
CTRA
4677
PUT
DELISTED
Coterra Energy
CTRA
| $270K | ﹤0.01% |
12,000
-4,000
| -25% | -$93.4K |
|
4678
PDF Solutions
PDFS
$2.15B
| $269K | ﹤0.01% |
29,767
+19,694
| +196% | +$198K |
|
|
EPZM
4679
DELISTED
Epizyme, Inc
EPZM
| $268K | ﹤0.01% |
25,306
+19,650
| +347% | +$224K |
|
4680
Beazer Homes USA
BZH
$872M
| $267K | ﹤0.01% |
25,380
+18,470
| +267% | +$243K |
|
4681
Great Southern Bancorp
GSBC
$889M
| $267K | ﹤0.01% |
4,814
+3,708
| +335% | +$218K |
|
|
CHS
4682
CALL
DELISTED
Chicos FAS, Inc.
CHS
| $267K | ﹤0.01% |
30,800
-23,300
| -43% | -$207K |
|
|
BMS
4683
PUT
DELISTED
Bemis
BMS
| $267K | ﹤0.01% |
5,500
+200
| +4% | +$9.45K |
|
|
BVH
4684
DELISTED
Bluegreen Vacations Holding Corporation
BVH
| $266K | ﹤0.01% |
7,185
+5,519
| +331% | +$221K |
|
|
ILPT
4685
Industrial Logistics Properties Trust
ILPT
$595M
| $265K | ﹤0.01% |
11,490
+6,312
| +122% | +$146K |
|
4686
PUT
Zillow
ZG
$7.91B
| $265K | ﹤0.01% |
6,000
-400
| -6% | -$20.9K |
|
|
HOLI
4687
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
| $265K | ﹤0.01% |
12,398
-81,500
| -87% | -$1.77M |
|
|
IMPV
4688
PUT
DELISTED
Imperva, Inc.
IMPV
| $265K | ﹤0.01% |
5,700
+4,700
| +470% | +$227K |
|
4689
iShares MSCI BIC ETF
BKF
$76.5M
| $264K | ﹤0.01% |
6,555
| – | – |
|
4690
Amplify Alternative Harvest ETF
MJ
$110M
| $264K | ﹤0.01% |
+550
| New | +$207K |
|
4691
CALL
Nu Skin
NUS
$234M
| $264K | ﹤0.01% |
3,200
+100
| +3% | +$7.95K |
|
|
WMC
4692
DELISTED
Western Asset Mortgage Capital Corporation
WMC
| $264K | ﹤0.01% |
2,633
+1,420
| +117% | +$154K |
|
4693
Global Industrial
GIC
$1.48B
| $263K | ﹤0.01% |
7,972
+7,078
| +792% | +$268K |
|
4694
VEON
VEON
$3.93B
| $263K | ﹤0.01% |
3,637
-3,406
| -48% | -$247K |
|
|
EGRX
4695
PUT
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $263K | ﹤0.01% |
+3,800
| New | +$288K |
|
4696
CALL
Cameco
CCJ
$42.6B
| $262K | ﹤0.01% |
23,000
-169,000
| -88% | -$1.78M |
|
4697
CALL
Celanese
CE
$5.01B
| $262K | ﹤0.01% |
2,300
+2,200
| +2,200% | +$252K |
|
4698
PUT
LiveRamp
RAMP
$2.3B
| $262K | ﹤0.01% |
5,300
+600
| +13% | +$26.6K |
|
4699
RadNet
RDNT
$6.01B
| $262K | ﹤0.01% |
17,366
+2,103
| +14% | +$30K |
|
4700
CALL
Sempra
SRE
$56.5B
| $262K | ﹤0.01% |
4,600
+1,400
| +44% | +$81K |
|
Similar funds
Barclays's Q3 2018 Portfolio in Review
As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
By sector, the portfolio is most concentrated in Technology at 8.3% of assets, up from 7.5% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.
- Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
- Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
- Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
- Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
- Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
- Barclays opened 680 new positions and closed 408 in Q3 2018.
- Barclays's portfolio value rose 24% quarter-over-quarter to $144B.
Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.